← Back to Search

Educational Materials and Chronic Disease Management Test (CDMT) for Cardiometabolic Syndrome

N/A
Waitlist Available
Research Sponsored by Qure Healthcare, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have practiced as a board-certified physician in internal or family medicine or greater than 2 but less than 30 years
Community / non-academic based practice setting
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing how well primary care physicians can manage common patient problems.

Eligible Conditions
  • Cardiometabolic Syndrome

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have practiced as a board-certified physician in internal or family medicine for more than 2 but less than 30 years.
Select...
A community or non-academic based practice setting involves working with people who are not students
Select...
The text generally discusses treatment for various heart conditions, such as atrial fibrillation, coronary artery disease, congestive heart failure, diabetes, hypertension, and hyperlipidemia.
Select...
≥ 40 patients are cared for every week.
Select...
is a basic human right Everyone has the right to access the internet.
Select...
You are a medical doctor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CPV-measured clinical score difference(drug, procedures, counseling and other)
CPV-measured cost difference
Test Adoption Rate
Secondary outcome measures
CPV-measured baseline variation
CPV-measured clinical score differences by use case
CPV-measured cost differences by use case

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Educational Materials and CDMT Test Results when Selected (Intervention 2)Experimental Treatment1 Intervention
Participants will care for the same set of CPV patients as the control arm, but will be educated on and will receive the CDMT test results only if they select it. Investigators will compare intervention participants' clinical recommendations to those in the control arm.
Group II: Educational Materials and CDMT Test Results (Intervention 1)Experimental Treatment1 Intervention
Participants will care for the same set of CPV patients as the control arm, but will be educated on and will receive the CDMT test results whether they select it or not. Investigators will compare intervention participants' clinical recommendations to those in the control arm.
Group III: ControlActive Control1 Intervention
These providers will complete two rounds of three simulated patient cases (CPVs). Control arm physicians will continue to have access to standard of care diagnostic tools, but not the CDMT test results.

Find a Location

Who is running the clinical trial?

Qure Healthcare, LLCLead Sponsor
21 Previous Clinical Trials
3,706 Total Patients Enrolled
1 Trials studying Cardiometabolic Syndrome
114 Patients Enrolled for Cardiometabolic Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period for this clinical trial open at present?

"As reported via clinicaltrials.gov, the trial initially posted on October 22nd 2021 is no longer recruiting patients at this time. However, there are currently 221 other trials that welcome participants to join their medical studies."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
QURE Healthcare
What portion of applicants met pre-screening criteria?
Met criteria
~73 spots leftby Mar 2025